|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/46 | |
| A61K 45/06 | |||
| A61P 35/00 | |||
| A61P 43/00 | |||
| A61K 31/704 | |||
| A61K 31/513 | |||
| A61K 31/675 | |||
| A61K 31/7068 | |||
| A61K 31/7048 |
| (11) | Patento numeris | 3368064 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15907392.3 |
| Europos patento paraiškos padavimo data | 2015-10-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-09-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-05-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/RU2015/000721 |
| Data | 2015-10-29 |
| (87) | Numeris | WO 2017/074211 |
| Data | 2017-05-04 |
| (72) |
GENKIN, Dmitry Dmitrievich, RU
TETS, Georgy Viktorovich, RU
TETS, Viktor Veniaminovich, RU
|
| (73) |
CLS Therapeutics Limited,
Frances House, Sir William Place St. Peter Port, Guernsey, Channel Islands, GY1 1GX,
GG
|
| (54) | USE OF DNASE TO IMPROVE SAFETY AND EFFICACY OF ANTI-CANCER CHEMOTHERAPY |
| USE OF DNASE TO IMPROVE SAFETY AND EFFICACY OF ANTI-CANCER CHEMOTHERAPY |